Heme oxygenase-1, the key enzyme for synthesizing bilirubin, may be upregulated to deal with oxidative stress during the stages of prediabetes and new-onset diabetes, and leading to an increase in the downstream product bilirubin so as to play antioxidant effects. This evidence concerns the gene HMOX1 and prediabetes syndrome.